1040-D Identification of four clinically-relevant immunomodulatory programs shared across nearly all glioma-associated myeloid cells
Tyler E. Miller(Case Comprehensive Cancer Center), B Bernstein(Broad Institute), Kevin Petrecca(McGill University Health Centre), Joshua P. D’Antonio(Harvard University), Mario L. Suvà(Broad Institute), Chadi A. El Farran(Broad Institute), Alex K. Shalek(Broad Institute), Zeyu Chen(Tongji University), Charles Couturier(Broad Institute)
Cited by 0
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Comprehensive Mapping of Long-Range Interactions Reveals Folding Principles of the Human Genome
|Science|2009|9.6k